We measured plasma human herpesvirus 8 (HHV8) DNA load in consecutive patients presenting with HIV-associated multicentric Castleman disease (MCD) and in contemporaneous patients who had Kaposi sarcoma (KS), lymphoma or other diagnoses. All 11 patients with MCD had detectable plasma HHV8 DNA compared with 18 (72%) of 25 patients with KS, none with lymphoma and one of 38 patients with other diagnoses. Detectable plasma HHV8 DNA levels were higher among MCD patients, median (interquartile range [IQR]) = 43,500 (5200–150,000) copies/mL, when compared with those with KS, median (IQR) = 320 (167–822) copies/mL and those with lymphoma and other diagnoses (one-way analysis of variance; P = 0.0303). Using receiver operating characteristic analysis, a cut-off of >1000 copies HHV8 DNA/mL of plasma helped to discriminate between MCD and other diagnoses, with a specificity of 94.7% and a negative predictive value of 97.3%. The level of HHV8 viraemia, while not diagnostic, may aid discrimination between patients with MCD and those with KS and other systemic illnesses.
ChangY, CesarmanE, PessinMS, Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science1994;266:1865–9
2.
WhitbyD, HowardMR, Tenant-FlowersM, Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet1995;346:799–802
3.
MoorePS, ChangY. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV. N Engl J Med1995;332:1181–5
4.
DupinN, FisherC, KellamP, Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci USA1999;96:4546–51
5.
SoulierJ, GrolletL, OksenhendlerE, Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood1995;86:1276–80
6.
CesarmanE, ChangY, MooreP, Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med1995;332:1186–91
LuppiM, BarozziP, SchulzTF, Bone marrow failure associated with human herpesvirus 8 infection after transplantation. N Engl J Med2000;343:1378–85
9.
KapelushnikJ, AriadS, BenharrochD, Post renal transplantation human herpesvirus 8-associated lymphoproliferative disorder and Kaposi's disorder. Br J Haematol2001;113:425–8
10.
BoivinG, CoteS, CloutierN, AbedY, MaguigadM, RoutyJP. Quantification of human herpesvirus 8 by real-time PCR in blood fractions of AIDS patients with Kaposi's sarcoma and multicentric Castleman's disease. J Med Virol2002;68:399–403
11.
SimonelliC, TedeschiR, GloghiniA, Plasma HHV-8 viral load in HHV-8-related lymphoproliferative disorders associated with HIV infection. J Med Virol2009;81:888–96
12.
PowlesT, StebbingJ, BazeosA, The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman's disease. Ann Oncol2009;20:775–9
13.
MarcelinA-G, MotolJ, GuihotA, relationship between the quantity of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated disease. J Infect Dis2007;196:1163–6
14.
TedeschiR, MarusA, BidoliE, Human herpesvirus 8 DNA quantification in matched plasma and PBMCs samples of patients with HHV8-related lymphoproliferative diseases. J Clin Virol2008;43:255–9
15.
GrandadamM, DupinN, CalvezV, Exacerbations of clinical symptoms in human immunodeficiency virus type 1-infected patients with multicentric Castleman's disease are associated with a high increase in Kaposi's sarcoma herpesvirus DNA load in peripheral blood mononuclear cells. J Infect Dis1997;175:1198–1201
16.
OksenhendlerE, CarcelainG, AokiY, High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric Castleman disease in HIV-infected patients. Blood2000;96:2069–73
17.
StebbingJ, PantanowitzL, DayyaniF, HIV-associated multicentric Castleman's disease. Am J Hematol2008;83:498–503
18.
MylonaE, BaraboutisI, LekakisL, Multicentric Castleman's disease in HIV infection: a systematic review of the literature. AIDS Rev2008;10:25–35
19.
GerardL, BerezneA, GalicierL, Prospective study of Rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric castleman's disease: ANRS 117 CastlemaB Trial. J Clin Oncol2007;25:3350–6
20.
ArmstrongW, KatzJT, KazanjianPH. Human immunodeficiency virus-associated fever of unknown origin: a study of 70 patients in the United States and review. Clin Infect Dis1999;28:341–5
21.
LoweSM, KocjanGI, EdwardsSG, MillerRF. Diagnostic yield of fine-needle aspiration cytology in HIV-infected patients with lymphadenopathy in the era of highly active antiretroviral therapy. Int J STD AIDS2008;19:553–6
22.
LeeSM, EdwardsS, ChiltonDN, Highly active antiretroviral therapy alone may be an effective treatment for HIV-associated multicentric Castleman disease. Haematologica2010;95:1979–81
23.
BarkerR, KazmiF, StebbingJ, FDG-PET/CT imaging in the management of HIV-associated multicentric Castleman's disease. Eur J Nucl Med Mol Imaging2009;36:648–52
24.
BourbouliaD, AldamD, LagosD, Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia. AIDS2004;18:485–93
25.
GarsonJA, GrantPR, AyliffeU, Real-time PCR quantitation of hepatitis B virus DNA using automated sample preparation and murine cytomegalovirus internal control. J Virol Methods2005;126:207–13
26.
GroggKL, MillerRF, DoganA. HIV infection and lymphoma. J Clin Pathol2007;60:1365–72
27.
MosamA, ShaikF, UldrickT, The KAART Trial: a randomised controlled trial of HAART compared to the combination of HAART and chemotherapy in treatment naive patients with HIV-associated Kaposi's sarcoma (HIV-KS) in KwaZulu-Natal (KZN), South Africa NCT 00380770. See http://retroconference.org/2010/Abstracts/37878.htm (last accessed 10 October 2010)
28.
LanzafameM, CarrettaG, TrevenzoliM, LazzariniL, Vento Ercole ConciaS. Successful treatment of Castleman's disease with HAART in two HIV-infected patients. J Infect2000;40:90–1
29.
SprinzE, JeffmanM, LeidkeP, Successful treatment of AIDS related Castleman's disease following the administration of HAART. Ann Oncol2004;15:356–8
30.
UldrickT, WanfgV, O'MahonyD, An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpes virus and HIV but without multicentric Castleman disease. Clin Infect Dis2010;51:350–8
